About NeuroQore
NeuroQore is a Healthcare company based in Ottawa (Canada) founded in 2012. Monophasic rTMS systems for depression treatment are developed by NeuroQore. It operates on a HealthTech model. NeuroQore has raised $1.76 million across 2 funding rounds from investors including IndieBio. NeuroQore offers products and services including Neuromodulation Treatment. Its focus areas include Medical Technology and Neuromodulation Devices.
Company details
NeuroQore is engaged in the development of pioneering neuromodulation treatments targeting various neurobehavioral conditions, with a primary focus on major depressive disorder and suicidality. Collaboration with world-class universities and research clinics is maintained to explore transformative solutions. The healthcare gap in effective interventions for treatment-resistant depression and acute suicidality is addressed through innovative approaches. Efforts are directed towards creating impactful solutions for devastating disorders affecting millions globally.
- Headquarters Ottawa, Canada
- SectorsHealthcare
- Phone•••• ••••
- Website neuroqore.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$1.76M (USD)
in 2 rounds
- Latest Funding Round$1.51M (USD), Series A
Jul 2025
- Investors
Products & Services of NeuroQore
NeuroQore offers a comprehensive portfolio of products and services, including Neuromodulation Treatment.
Innovative neuromodulation treatments for neurobehavioral conditions are developed.
Apps and channels of NeuroQore
its YouTube channel NeuroQore, Inc. has 9 subscribers.
Funding Insights of NeuroQore
NeuroQore has successfully raised a total of $1.76M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.51 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.76M
- Total Rounds 2
- Last Round Series A — $1.51M
- First Round $250,000
(Oct 2016)
- Investors Count 1
All 2 funding rounds of NeuroQore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2025 | $1.51M | Series A | – | – | – |
| Oct 2016 | $250,000 | Seed | – | IndieBio | – |
1 investors in total: 1 institutional.
Investors in NeuroQore
NeuroQore has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | indiebio.co | San Francisco, United States |
Investor details for NeuroQore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NeuroQore
3 dated milestones of NeuroQore across 13 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroQore is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series A, of $1.5M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neuroqore
Complete news archive for NeuroQore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroQore
NeuroQore was founded in 2012 and raised its 1st funding round 4 years after it was founded.
NeuroQore is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
NeuroQore is a funded company, having raised a total of $1.76M across 2 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Oct 2016.
NeuroQore is engaged in the development of pioneering neuromodulation treatments targeting various neurobehavioral conditions, with a primary focus on major depressive disorder and suicidality. Collaboration with world-class universities and research clinics is maintained to explore transformative solutions. The healthcare gap in effective interventions for treatment-resistant depression and acute suicidality is addressed through innovative approaches. Efforts are directed towards creating impactful solutions for devastating disorders affecting millions globally.
NeuroQore offers Neuromodulation Treatment.
NeuroQore has 1 investor. Key investors include IndieBio.